REGENXBIO INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2024)
$161.32M
Revenue
$-177.91M
Net Income
-3.46
EPS (Diluted)
$-90.81M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-96.04%
Net Profit Margin
-110.29%
EBITDA
$-127.35M
Returns & Efficiency
Return on Assets (ROA)
-33.88%
Return on Equity (ROE)
-110.20%
Gross Profit
-
Operating Income
$-154.93M
Financial Health
Total Assets
$525.20M
Total Debt
-
Debt to Equity
2.25x
Current Ratio
2.66
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$-3.46
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850 |
| Phone | 240-552-8181 |
| Incorporated | None, None |
| EIN | 471851754 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 51.69M |
| Stockholders' Equity | $161.45M |
| Cash & Equivalents | $58.80M |
Recent Filings
View All
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-10
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-03-05
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-05
Local
424B5
Prospectus Supplement
Prospectus supplement filed under Rule 424(b)(5)
Filed: 2026-02-12
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-10
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-12
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-04-08
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-03-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-01
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-08
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-04-04
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-02-27
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
-
Operating Margin
-96.0%
Net Margin
-110.3%
ROE
-110.2%
ROA
-33.9%
Leverage & Liquidity
Debt to Equity
2.25
Current Ratio
2.66
Total Debt
-
Total Assets
$525.20M
Stockholders' Equity
$161.45M
Income Statement (FY 2024)
Revenue
$161.32M
Gross Profit
-
Operating Income
$-154.93M
Net Income
$-177.91M
EPS (Diluted)
$-3.46
Cash Flow (FY 2024)
Free Cash Flow
$-90.81M
Cash & Equivalents
$58.80M
Revenue Growth
93.6%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...